Neutrophil Lymphocyte Ratio to Albumin Ratio and White Blood Cell to Hemoglobin Ratio as Prognostic Markers for Hepatocellular Carcinoma Patients Who Underwent Curative Hepatectomy

被引:11
作者
Shen, Xueqin [1 ]
Wang, Wei [1 ]
Niu, Xiaoping [1 ]
机构
[1] Wannan Med Coll, Dept Gastroenterol, Yijishan Hosp, 2 Zheshan Rd, Wuhu 241000, Anhui, Peoples R China
关键词
hepatocellular carcinoma; neutrophil lymphocyte ratio to albumin ratio; white blood cell to hemoglobin ratio; prognosis; overall survival; curative hepatectomy; CANCER; PREDICTORS; RESECTION; SURVIVAL;
D O I
10.2147/IJGM.S329911
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Inflammation factors affect the prognosis of hepatocellular carcinoma (HCC). However, it is not clear if the preoperative neutrophil lymphocyte ratio to albumin ratio (NLRAR) and white blood cell to hemoglobin ratio (WHR) affect the prognosis of HCC post curative hepatectomy. We assessed the prognostic values of NLRAR and WHR in patients suffering from HCC who underwent curative resection. Materials and Methods: A total of 169 eligible HCC cases were reviewed. The optimal cut-off values for NLRAR and WHR were selected using the X-tile software. The overall survival (OS) rate was assessed following the Kaplan-Meier analysis method. The Log rank test and Cox proportional hazard regression model were also used to analyze the data. The prognostic values of NLRAR and WHR were calculated by analyzing the area under the receiver operating characteristic curve (AUC). The decision curve analysis (DCA) was performed for clinical benefits. Results: The OS rate recorded for the high NLRAR group was poorer than the OS rate recorded for the low NLRAR group. Similar trends were observed for WHR. The NLRAR and WHR were the independent predictors of OS. The results were based on the multivariate Cox analyses method. Results obtained by analyzing the subgroups revealed that NLRAR and WHR could be used for the prognosis of HCC in tumor stage I-patients. The NLRAR-WHR scoring system (NWS) could be used to classify HCC patients into two cohorts with different prognoses. This scoring system was more efficient than NLRAR or WHR in predicting OS. Conclusion: The preoperative NLRAR and WHR are effective prognostic indicators for HCC in patients who underwent curative hepatectomy.
引用
收藏
页码:5029 / 5038
页数:10
相关论文
共 28 条
[1]   The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging [J].
Amin, Mahul B. ;
Greene, Frederick L. ;
Edge, Stephen B. ;
Compton, Carolyn C. ;
Gershenwald, Jeffrey E. ;
Brookland, Robert K. ;
Meyer, Laura ;
Gress, Donna M. ;
Byrd, David R. ;
Winchester, David P. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (02) :93-99
[2]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[3]   X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization [J].
Camp, RL ;
Dolled-Filhart, M ;
Rimm, DL .
CLINICAL CANCER RESEARCH, 2004, 10 (21) :7252-7259
[4]   Platelet-to-lymphocyte ratio is an independent prognosticator in patients with esophageal squamous cell carcinoma receiving esophagectomy [J].
Chen, Li-Chun ;
Li, Shau-Hsuan ;
Lo, Chien-Ming ;
Chen, Yen-Hao ;
Huang, Shun-Chen ;
Wang, Yu-Ming ;
Chou, Shang-Yu ;
Lu, Hung-I .
JOURNAL OF THORACIC DISEASE, 2019, 11 (11) :4583-4590
[5]   An evaluation of the preoperative hemoglobin level as a prognostic factor for oral squamous cell carcinoma [J].
Cordella, Claudia ;
Luebbers, Heinz-Theo ;
Rivelli, Valentina ;
Graetz, Klaus W. ;
Kruse, Astrid L. .
HEAD & NECK ONCOLOGY, 2011, 3
[6]   Single measurement of hemoglobin predicts outcome of HCC patients [J].
Finkelmeier, Fabian ;
Bettinger, Dominik ;
Koeberle, Verena ;
Schultheiss, Michael ;
Zeuzem, Stefan ;
Kronenberger, Bernd ;
Piiper, Albrecht ;
Waidmann, Oliver .
MEDICAL ONCOLOGY, 2014, 31 (01)
[7]   The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer [J].
Guthrie, Graeme J. K. ;
Charles, Kellie A. ;
Roxburgh, Campbell S. D. ;
Horgan, Paul G. ;
McMillan, Donald C. ;
Clarke, Stephen J. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 88 (01) :218-230
[8]   Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach-The ALBI Grade [J].
Johnson, Philip J. ;
Berhane, Sarah ;
Kagebayashi, Chiaki ;
Satomura, Shinji ;
Teng, Mabel ;
Reeves, Helen L. ;
O'Beirne, James ;
Fox, Richard ;
Skowronska, Anna ;
Palmer, Daniel ;
Yeo, Winnie ;
Mo, Frankie ;
Lai, Paul ;
Inarrairaegui, Mercedes ;
Chan, Stephen L. ;
Sangro, Bruno ;
Miksad, Rebecca ;
Tada, Toshifumi ;
Kumada, Takashi ;
Toyoda, Hidenori .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (06) :550-U45
[9]   Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems [J].
Liu, Po-Hong ;
Hsu, Chia-Yang ;
Hsia, Cheng-Yuan ;
Lee, Yun-Hsuan ;
Su, Chien-Wei ;
Huang, Yi-Hsiang ;
Lee, Fa-Yauh ;
Lin, Han-Chieh ;
Huo, Teh-Ia .
JOURNAL OF HEPATOLOGY, 2016, 64 (03) :601-608
[10]   Impact of preoperative anemia on outcomes in patients undergoing curative resection for gastric cancer: a single-institution retrospective analysis of 2163 Chinese patients [J].
Liu, Xuechao ;
Qiu, Haibo ;
Huang, Yuying ;
Xu, Dazhi ;
Li, Wei ;
Li, Yuanfang ;
Chen, Yingbo ;
Zhou, Zhiwei ;
Sun, Xiaowei .
CANCER MEDICINE, 2018, 7 (02) :360-369